Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
Arch Mal Coeur Vaiss ; 79(2): 228-34, 1986 Feb.
Artigo em Francês | MEDLINE | ID: mdl-2871818

RESUMO

The ergometric effects of different vasodilator drugs in 5 series of 10 patients with stable angina and persistent effort ischaemia despite beta-offckade, were compared two by two in a random, single blind cross-over study under basal conditions on betablocker therapy and at the peak of their action, the second measurement being performed after a 2 to 7 day interval. The principal criteria of assessment were the work required to induce 1 mm ST depression (WST1), and the maximum ST depression (ST max) at comparable work loads. Molsidomine (2 mg), Risordan 20 mg) and Nifedipine (10 mg) significantly improved both parameters (p less than 0.001). Lenitral (7.5 mg), Langoran (40 mg), Trinitrin skin patch (10 mg) did not produce a significant improvement. Corditrine improved WST1 (p less than 0.05) and slow release Trinitrin (2.5 and 5 mg) improved WST1 at 3 hours (p less than 0.05) and ST max at 15 minutes (p less than 0.001) and 3 hours (p less than 0.05). The fall in resting blood pressure was parallel to the ergometric changes. These results suggest that Molsidomine, Nifedipine, Risordan and slow release Trinitrin (2.5 mg) are the most effective vasodilators when used in association with betablockers.


Assuntos
Antagonistas Adrenérgicos beta/administração & dosagem , Angina Pectoris/tratamento farmacológico , Vasodilatadores/administração & dosagem , Adulto , Idoso , Ensaios Clínicos como Assunto , Quimioterapia Combinada , Eletrocardiografia , Teste de Esforço/métodos , Feminino , Hemodinâmica/efeitos dos fármacos , Humanos , Dinitrato de Isossorbida/administração & dosagem , Cinética , Masculino , Pessoa de Meia-Idade , Molsidomina , Nifedipino/administração & dosagem , Nitroglicerina/administração & dosagem , Sidnonas/administração & dosagem , Vasodilatadores/metabolismo , Vasodilatadores/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...